pyrimethamine has been researched along with Prostatic Hyperplasia in 1 studies
Maloprim: contains above 2 cpds
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajuonuma, BC | 1 |
| Ajuonuma, MU | 1 |
| Uzo-Ngerem, A | 1 |
| Ajuonuma, MK | 1 |
| Ajuonuma, FO | 1 |
| Chukwu, CL | 1 |
| Ajonuma, LC | 1 |
1 other study available for pyrimethamine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Sudden enlargement of the prostate in a patient taking Fansidar for malaria.
Topics: Aged; Antimalarials; Drug Combinations; Humans; Malaria; Male; Prostatic Hyperplasia; Pyrimethamine; | 2007 |